PLACES ARE LIMITED TO 40 PARTICIPANTS.
At the end of these conferences, participant will be able to:
Strategies to better manage the clinical gaps of the management of osteoporosis in the geriatric population
1. Describe the major human and economic cost associated with Osteoporosis in Canada;
2. Cite the risk factors for fragility fractures and identify patients that can benefit from BMD screening;
3. Cite the efficacy and safety of pharmacological and non pharmacological treatments available to prevent fragility fractures in high risk patients including the NNT and NNH ( or pharmacological tx) for vertebral and hip fractures respectively;
4. Identify community resources to help our patients prevent falls including the Programme Intégré d’Équilibre Dynamique (PIED) available at the CLSC's as endorsed by the INSPQ;
5. Learn how to apply the most current Osteoporosis Canada evidence-based fracture prevention recommendations in frail older adults residing in senior retirement homes and long-term care facilities including strategies to prevent falls in institutions in the context of the current healthcare climate.
Round Table Discussion on Dyslipidemia to prevent CVD, strategies to overcome clinical gaps
1. Using clinical cases, demonstrate and overcome clinical practice gaps to better manage ASCVD patients to prevent recurrent CV events;
2. Describe the thresholds for intensification of lipid-lowering therapy;
3. Integrate Lp(a), TAG values and patient history of pregnancy related conditions in applying the 2021 CCS dyslipidemia guidelines for the prevention of CVD.
Moderator : Dr. Jonathan Singerman. Conferences given by Drs. Jean-Pierre Raynauld and Michael Tsoukas.
From 17 h 35 to 17 h 45, Welcome
From 17 h 45 to 18 h 15, Meal
From 18 h 15 to 19 h 45, Conference
From 19 h 45 to 19 h 55, Break
From 19 h 55 to 21 h 25, Conference
This conference will be held at Molyvos Restaurant, located at 4235 A Decarie Blvd, Montreal, Qc H4A 3K4.
The AMOM recommends that all participants follow the provincial health guidelines related to the COVID-19 pandemic.
Participants acknowledge and accept the health risks that may be associated with in-person participation and understand that they are solely responsible for assessing their own health and taking appropriate safety measures for their situation.
An attendance list can be sent to the pharmaceutical company after the activity, if requested. By this registration, the general practitioner and/or any other healthcare professional consents to the disclosure of his first and last name to the pharmaceutical company.
The pharmaceutical company agrees not to communicate this information without the consent of the participant.
If you do not want your first and last name disclosed, please contact Ms. Aline Sabbagh at firstname.lastname@example.org indicating the activity number.
Recognition of Educational Activities
L’Association des médecins omnipraticiens de Montréal, under the aegis of the FMOQ, recognizes 3.00 hours of professional development activity, of category 1, as required by the professional development regulations of the CMQ. The FMOQ number to retrieve your certificate is 85655.
This activity has received an educational subsidy from Amgen Canada Inc.